Physiological Response and Experience Between Sitting in Bed and Sitting in a Chair in ICU

September 29, 2023 updated by: Göteborg University

Comparison of Physiological Response and Experience Between Sitting in Bed and Sitting in a Chair in Patients in Intensive Care

Background: In the work with early mobilization (EM), in intensive care, several types of EM are used A sitting in bed in semi- Fowler's position, sitting on the edge of the bed, and sitting in a chair. Nowadays, it is often possible to achieve a comfortable sitting in the beds in ICU. However, in a recent study by the same author group one of the findings was the importance to get out of bed. Getting out of bed was associated with decreasing feelings of hopelessness and being less ill. It also encouraged the will to fight for recovery.

There are few studies in intensive care that have examined what happens to circulation and oxygenation in various forms of sitting. Studies that examined the patient's own experience of sitting in bed compared to sitting in a chair are missing.

The aim is therefore to investigate physiological response and experience in patients in intensive care when sitting in bed or in a chair Method: Repeated measures randomized cross-over study Selection: Patients with respiratory and / or circulatory insufficiency requiring intensive care, Inclusion criteria: Approximately 30 respiratory and circulatory stable patients with emergency admission to intensive care. Aged over 18 years, who understands Swedish. The patient and / or relative are asked after the physician in charge has given medical approval. Recruitment is planned to be done by nurses in charge at the unit.

Exclusion criteria: Patients who have undergone planned surgery without complications.

Intervention: The participants in the study will be measured in two different positions; sitting in bed and sitting in chair. They are randomized to start either sitting in bed or in a chair and will sit for 20 minutes in each position, at 4 - hour intervals.

Data collection, physiological variables: The following physiological variables will be measured: Blood pressure and oxygenation by arterial needle and pulse by ECG. They will be measured before the intervention, at the beginning of the intervention, after ten minutes, at the end of the intervention and ten minutes afterwards Data collection, qualitative variables: Rating of the experience of exertion, pain and satisfaction.

Data analysis: Statistical analysis of differences between the two positions. For quantitative variables that are normally distributed, paired t-tests will be used. For qualitative variables and non-normally distributed quantitative variables, Wilcoxon character rank test or Mc Nemar test will be used

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gothenburg, Sweden, 41345
        • Göteborg University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • emergency admission to intensive care
  • age >18 years
  • understanding Swedish

Exclusion Criteria:

  • Respiratory or circulatory instability where mobilization is contraindicated

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Sitting in bed
Sitting in bed with 60 degrees elevated back-rest during 20 minutes
Mobilization to chair
Other Names:
  • Mobilization in bed
Experimental: Sitting in chair
Sitting in chair during 20 minutes
Mobilization to chair
Other Names:
  • Mobilization in bed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PaO2
Time Frame: Within 8 hours after inclusion
Arterial oxygen pressure
Within 8 hours after inclusion
PaCO2
Time Frame: Within 8 hours after inclusion
Arterial carbon dioxide pressure
Within 8 hours after inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure
Time Frame: Within 8 hours after inclusion
Systolic and diastolic pressure
Within 8 hours after inclusion
SpO2
Time Frame: Within 8 hours after inclusion
Oxygen saturation
Within 8 hours after inclusion
Perceived pain
Time Frame: Within 8 hours after inclusion.
Visual analogue scale from 0-100 mm
Within 8 hours after inclusion.
Perceived exertion
Time Frame: Within 8 hours after inclusion
Borg RPE scale from 6 to 20
Within 8 hours after inclusion
Perceived satisfaction
Time Frame: Within 8 hours after inclusion
Scale with 11 levels from 0 (no enjoyment) to 10 (maximum enjoyment).
Within 8 hours after inclusion
Staff ratings of pain during mobilization
Time Frame: Within 8 hours after inclusion
Visual analogue scale from 0-100 mm
Within 8 hours after inclusion
Staff ratings of exertion during mobilization
Time Frame: Within 8 hours after inclusion
Borg RPE scale from 6 to 20
Within 8 hours after inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

October 18, 2021

First Submitted That Met QC Criteria

November 11, 2021

First Posted (Actual)

November 12, 2021

Study Record Updates

Last Update Posted (Actual)

October 3, 2023

Last Update Submitted That Met QC Criteria

September 29, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • FoU i VGR:275466

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mobilization

Clinical Trials on Routine care

Subscribe